STAT+: Q&A: Califf on obesity drugs, advisory panels, and how threats hurt recruitment at FDA
STAT
MARCH 7, 2023
BOSTON — FDA Commissioner Robert Califf said on Monday that it “bothers” him that Novo Nordisk, which makes an obesity medication, funded the development of obesity coursework for medical schools. Continue to STAT+ to read the full story…
Let's personalize your content